NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Pharma Industry News Pfizer’s inotuzumab ozogamicin gains FDA priority review in acute lymphoblastic leukemia Pfizer Inc. has received a priority review designation from the U.S. Food and Drug Administration (FDA) for its… bypharmanewsdailyFebruary 23, 2017